Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 7/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | ELANE | P08246 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.37 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.37 |
| ▸ | RARB | P10826 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6523800 | 0.92 | L3MBTL1 (0.39) | TSHRRECQLL3MBTL1GAAMAPT | |
| SCHEMBL6520975 | 0.86 | ZDHHC2 (0.44) | FAAHSMN1; SMN2ZDHHC2 | |
| SCHEMBL6520633 | 0.86 | SMN1; SMN2 (0.39) | SMN1; SMN2ALDH1A1PLA2G4B | |
| SCHEMBL6514469 | 0.85 | SMN1; SMN2 (0.46) | FAAHSMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL6518690 | 0.84 | KMT2A (0.42) | POLBGAAMAPTELANEALDH1A1 | |
| SCHEMBL6516145 | 0.83 | TSHR (0.41) | TSHRRECQLSMN1; SMN2GAAMAPT | |
| SCHEMBL28029581 | 0.80 | RECQL (0.52) | TSHRRECQLFAAHMAPTELANE | |
| SCHEMBL6522453 | 0.80 | CYP19A1 (0.42) | L3MBTL1ATMMAPTELANEALDH1A1 | |
| SCHEMBL6520706 | 0.80 | MMP12 (0.43) | TSHRRECQLALDH1A1 | |
| SCHEMBL6514767 | 0.80 | KMT2A (0.42) | SMN1; SMN2L3MBTL1GAAMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | TSHR 3581/4885RECQL 2058/4885FAAH 920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.